Navigation Links
AAOS Issues New Treatment Guidelines for Carpal Tunnel Syndrome
Date:10/27/2008

ROSEMONT, Ill., Oct. 27 /PRNewswire-USNewswire/ -- The American Academy of Orthopaedic Surgeons (AAOS) has approved and released an evidence-based clinical practice guideline on "The Treatment of Carpal Tunnel Syndrome."

"Carpal Tunnel Syndrome, otherwise known as CTS, is among the most common disorders of the upper extremity. It affects up to ten percent of the population and is related to many factors, but is thought to be caused by increased pressure on the median nerve in the carpal tunnel in the wrist," said Michael Keith, M.D., Chair of the AAOS work group responsible for creating the new guideline.

-- According to the National Center for Health Statistics, in 2005, an

estimated 3.1 million people sought help from physicians for the

treatment of CTS.

"The Academy created this clinical practice guideline to improve patient care for those suffering from Carpal Tunnel Syndrome," stated Dr. Keith. "The document serves as a point of reference and educational tool for both family practitioners and orthopaedic surgeons, streamlining possible treatment processes for this ever-so common ailment."

In June 2007, the Journal of the Academy of Orthopaedic Surgeons (JAAOS) reported about 500,000 CTS surgical procedures are performed each year. The same study also reported the economic impact due to CTS is estimated to exceed $2 billion annually.

The final CTS Treatment guideline contains nine recommendations which include both operative and non-operative treatment options as well as alternative techniques. Some of the recommendations include:

-- Traditional bracing or splinting

-- Local steroid injection

-- Oral steroids

-- Ultrasound

-- Carpal tunnel release surgery

After doing a thorough analysis of the current literature, the work group found no evidence that supports the following treatments:

-- Heat therapy

-- Acupuncture

-- Diuretics

-- Electric stimulation

-- Massage therapy

-- Magnet therapy

-- Nutritional supplements

"This guideline is not intended to stand alone," added Dr. Keith. "It can be used as a starting point for physicians and can open up the lines of patient-physician communication on possible treatment options."

As new research, knowledge and literature on CTS becomes available, this guideline will be reviewed and re-evaluated by the Guidelines and Technology Oversight Committee. It will be considered for updating in three to five years, which is consistent with evidence-based standards.

The AAOS has released other evidence-based guidelines on musculoskeletal topics, including:

-- Diagnosis of Carpal Tunnel Syndrome

-- Prevention of Symptomatic Pulmonary Embolism (PE).

This guideline, which is aimed towards the treatment of Carpal Tunnel Syndrome in adults, was developed by an AAOS physician volunteer work group and was based upon a systematic review of the current scientific and clinical information on accepted approaches to treatment and/or diagnosis. The entire process from beginning to end lasted about eighteen months and included a review panel consisting of internal and external committees, public commentaries and final approval by the AAOS Board of Directors.

The full guideline along with all supporting documentation is available on the AAOS website: http://www.aaos.org/guidelines

http://www.orthoinfo.org

About AAOS


'/>"/>
SOURCE American Academy of Orthopaedic Surgeons
Copyright©2008 PR Newswire.
All rights reserved

Related medicine news :

1. College Mental Health Expert and Sister of Student Who Died By Suicide Available to Discuss College Mental Health Issues
2. PowerBar Issues Open Call for 2008-2009 PowerBar Team Elite(TM) Athlete Sponsorship Program
3. Crystal Research Associates, LLC Issues Executive Informational Overview(R) (EIO(R)) on Tapestry Pharmaceuticals, Inc.
4. American Red Cross Issues Blood Supply Alert
5. OSHA Issues Draft Ergonomics Guidelines on Preventing Musculoskeletal Injuries in Shipyards
6. New Survey Finds Strong Public Interest in Prescription Drug Safety Issues
7. National Quality Forum Issues First Consensus Standards for the Treatment of Substance Use Conditions
8. Audio: New Survey Finds Strong Public Interest in Prescription Drug Safety Issues
9. Dallas-Area Transplant Meeting Puts Spotlight on Key Issues
10. Elder Care Author Doctor Marion Launches Second National Tour to Raise Awareness About Aging & Elder Care Issues in America
11. California State PTA Issues Statement Regarding Presidents Veto of SCHIP Legislation
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:6/27/2016)... ... June 27, 2016 , ... ... only authorized OSHA Training Institute Education Center headquartered in Northern California, has issued ... from extreme heat at their worksites. Employers with workers exposed to high ...
(Date:6/27/2016)... ... 2016 , ... "FCPX editors can now reveal their media with growing colorful ... Christina Austin - CEO of Pixel Film Studios. , ProSlice Color brings the ... can now reveal the media of their split screens with growing colorful panels. , ...
(Date:6/27/2016)... ... June 27, 2016 , ... ... health professionals, announced today its affiliation with Tennessee Counseling Association. This ... the network of the Tennessee Counseling Association, adding exclusive benefits and promotional offers. ...
(Date:6/27/2016)... ... June 27, 2016 , ... ... today announced its strategic partnership with Connance, a healthcare industry leader providing ... companies’ proven, proprietary technology combine to provide health systems, hospitals and ambulatory ...
(Date:6/27/2016)... , ... June 27, 2016 , ... ... edge technology to revolutionize the emergency ambulance transport experience for the millions of ... of how Uber has disrupted the taxi industry through the use of technology. ...
Breaking Medicine News(10 mins):
(Date:6/26/2016)... 2016 One of Australia,s successful ... of a new biotechnology company, Noxopharm Limited [ABN 50 608 966 ... and to list on the ASX. Noxopharm is a ... enter a Phase 1 clinical study later this year. ... of the biggest problems facing cancer patients - the ability of ...
(Date:6/26/2016)... 27, 2016 Jazz Pharmaceuticals plc (Nasdaq: ... the Hart-Scott-Rodino Antitrust Improvements Act of 1976, as amended ... Pharmaceuticals, Inc. ("Celator"; Nasdaq: CPXX ) expired ... Time). As previously announced on May 31, ... merger agreement under which Jazz Pharmaceuticals has commenced a ...
(Date:6/26/2016)... , June 27, 2016  VMS Rehab Systems, ... Board will take whatever measures required to build a ... stock which is currently listed on the OTC Markets-pink ... Company Chairman and CEO, "We are seeing an anomaly ... to understand, not only by the Company, but shareholders ...
Breaking Medicine Technology: